EMAIL THIS PAGE TO A FRIEND

Journal of agricultural and food chemistry

In vitro and in vivo studies on adlay-derived seed extracts: phenolic profiles, antioxidant activities, serum uric acid suppression, and xanthine oxidase inhibitory effects.


PMID 25029106

Abstract

This study aimed to explore the potential of polished adlay, brown adlay, adlay bran, and adlay hull to prevent and treat hyperuricemia. Brown adlay extract effectively decreased the serum uric acid levels of oxonate-induced hyperuricemic rats. Free and bound phenolic extracts from these materials contained significant amounts of phenolics, with free phenolics dominated by chlorogenic acid and p-coumaric acid while bound phenolics dominated by p-coumaric acid and ferulic acid. Free and bound phenolics of adlay bran exhibited significant xanthine oxidase inhibition activities, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activities, oxygen radical absorbance capacities, and superoxide radical scavenging activities. Adlay bran phenolics could be effective xanthine oxidase inhibitors and radical scavengers. p-Coumaric acid is a xanthine oxidase inhibitor with strong superoxide radical scavenging activity. However, ferulic acid is a xanthine oxidase inhibitor with weak superoxide radical scavenging activity. Chlorogenic acid is a superoxide radical scavenger with weak xanthine oxidase inhibitory activity.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

37580
3,4-Dihydroxybenzoic acid, ≥97.0% (T)
C7H6O4
08992
3,4-Dihydroxybenzoic acid, analytical standard
C7H6O4
A8003
Allopurinol, xanthine oxidase inhibitor
C5H4N4O
A0350000
Allopurinol, European Pharmacopoeia (EP) Reference Standard
C5H4N4O
PHR1377
Allopurinol, Pharmaceutical Secondary Standard; Certified Reference Material
C5H4N4O
1013002
Allopurinol, United States Pharmacopeia (USP) Reference Standard
C5H4N4O
C0625
Caffeic acid, ≥98.0% (HPLC)
C9H8O4
60018
Caffeic acid, matrix substance for MALDI-MS, ≥99.0% (HPLC)
C9H8O4
60020
Caffeic acid, purum, ≥95.0% (HPLC)
C9H8O4
C3878
Chlorogenic acid, ≥95% (titration)
C16H18O9
00500590
Chlorogenic acid, primary pharmaceutical reference standard
C16H18O9
Y0000569
Chlorogenic acid, European Pharmacopoeia (EP) Reference Standard
C16H18O9
Y0001013
Ferulic acid, European Pharmacopoeia (EP) Reference Standard
C10H10O4
F6377
Fluorescein sodium salt, used as fluorescent tracer
C20H10Na2O5
46960
Fluorescein sodium salt, BioReagent, suitable for fluorescence
C20H10Na2O5
30181
Fluorescein sodium salt, analytical standard
C20H10Na2O5
46970
Fluorescein sodium salt, p.a., for source staining
C20H10Na2O5
03930590
Protocatechuic acid, primary pharmaceutical reference standard
C7H6O4
46278
trans-Ferulic acid, matrix substance for MALDI-MS, ≥99.0% (HPLC)
C10H10O4
W518301
trans-Ferulic acid, ≥99%
C10H10O4
128708
trans-Ferulic acid, 99%
C10H10O4
52229
trans-Ferulic acid, certified reference material, TraceCERT®
C10H10O4
94770
Vanillic acid, purum, ≥97.0% (HPLC)
C8H8O4
H36001
Vanillic acid, 97%
C8H8O4
W398802
Vanillic acid, ≥97%, FG
C8H8O4
68654
Vanillic acid, certified reference material, TraceCERT®
C8H8O4
X0626
Xanthine, ≥99.5% (HPLC), purified by recrystallization
C5H4N4O2
X4002
Xanthine, BioUltra, ≥99%
C5H4N4O2
X7375
Xanthine, ≥99%
C5H4N4O2